A comparison of two FDA approved lamotrigine immunoassays with ultra-high performance liquid chromatography tandem mass spectrometry

Clinica Chimica Acta

Volumn 412, Issue 19-20, 2011, Pages 1879-1882

  Juenke, JoEtta M ^a   Miller, Kendall A ^a   Ford, Meredith A ^a   McMillin, Gwendolyn A ^a,b   Johnson Davis, Kamisha L ^a,b  

^a ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Immunoassay; Lamotrigine; Therapeutic drug monitoring

Indexed keywords

LAMOTRIGINE;

ANALYTICAL EQUIPMENT; ARTICLE; AUTOANALYZER; CLINICAL ARTICLE; CONTROLLED STUDY; DILUTION; DRUG DETERMINATION; FOOD AND DRUG ADMINISTRATION; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; LIMIT OF QUANTITATION; PRIORITY JOURNAL; QUALITY CONTROL; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; IMMUNOASSAY; REPRODUCIBILITY OF RESULTS; TANDEM MASS SPECTROMETRY; TRIAZINES; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 79960637238     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2011.06.009     Document Type: Article

References (16)

1. Leach M.J., Marden C.M., Miller A.A. Pharmacological studies on lamotrigine, a novel antiepileptic drug II. Neurochemical studies on the mechanism of action. Epilepsia 1986, 27:490-497.
2. Neels H.M., Sierens A.C., Naelerts K., Scharpe S.L., Hatfield G.M., Lambert W.E. Therapeutic drug monitoring of old and newer anti-epileptic drugs. Clin Chem Lab Med 2004, 42:1228-1255.
3. Patsalos P.N., Berry D.J., Bourgeois B.D.F., Cloyd J.C., Glauser T.A., Johannessen S.I., Tomson T., Perucca E. Antiepileptic drugs - best practice guidelines for therapeutic drug monitoring: a position paper by the subcommision on therapeutic drug monitoring, ILAE Commision on Therapeutic Strategies. Epilepsa 2008, 49:1239-1276.
4. LaRoche S.M., Helmers S.L. The new antiepileptic drugs: clinical applications. JAMA 2004, 291:615-620.
5. Pennell P.B., Peng L., Mewport D.J., Ritchie J.C., Koganti A., Holley D.K., Newman M., Stowe Z.N. Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency. Neurology 2008 May 27, 70(22 Pt 2):2130-2136.
6. Wegner I., Edelbroek P., de Haan G.J., Lindhout D., Sander J.W. Drug monitoring of lamotrigine and oxcarbazepine combination during pregnancy. Epilepsia 2010 Dec, 51(12):2500-2502.
7. Chang C.C., Shiah I.S., Yeh C.B., Wang T.S., Chang H.A. Lamotrigine-associated anticonvulsant hypersensitivity syndrome in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 2006 Jun, 30(4):741-744.
8. Johannessen Landmark C., Patsalos P.N. Drug interactions involving the new second and third-generation antiepileptic drugs. Expert Rev Neurother 2010 Jan, 10(1):119-140.
9. Wolf P. Lamotrigine: preliminary clinical observations on pharmacokinetics and interactions with traditional antiepileptic drugs. J Epilepsy 1992, 5:73-79.
10. Brodie M.J. Lamotrigine. Lancet 1992, 339:1397-1400.
11. Contin M., Mohamed S., Candela C., Albani F., Riva R., Baruzzi A. Simultaneous HPLC-UV analysis of rufinamide, zonisamide, lamotrigine, oxcarbazepine monohydroxy derivative and felbamate in deproteinized plasma of patients with epilepsy. J Chromatogr B Analyt Technol Biomed Life Sci 2010 Feb 1, 878(3-4):461-465.
12. Subramanian M., Birnbaum A.K., Remmel R.P. High-speed simultaneous determination of nine antiepileptic drugs using liquid chromatography-mass spectrometry. Ther Drug Monit 2008 Jun, 30(3):347-356.
13. Hallbach J., Vogel H., Guder W.G. Determination of lamotrgine, carbamazepine and carbamazepine epoxide in human serum by gas chromatography mass spectrometry. Eur J Clin Chem Clin Biochem 1997 Oct, 35(10):755-759.
14. Dasgupta A., Hart A.P. Lamotrigine analysis in plasma by gas chromatography-mass spectrometry after conversion to a tert.-butyldimethlysilyl derivative. J Chromatogr B Biomed Sci Appl 1997 May 23, 693(1):101-107.
15. Queiroz M.E., Silva S.M., Carvalho D., Lancas F.M. Determination of lamotrigine simultaneously with carbamazepine, carbamazepine epoxide, phenytoin, phenobarbital, and primidone in human plasma by SPME-GC-TSD. J Chromatogr Sci 2002 Apr, 40(4):219-223.
16. Juenke J.M., McMillin G.A. Analytical support of classical anticonvulsant drug monitoring beyond immunoassay: applications of chromatographic methods. Advances in chromatographic techniques for therapeutic drug monitoring 2010, 85-101. CRC Press, Boca Raton. A. Dasgupta (Ed.).